Dhanak Dashyant's Form 4 filing
Incyte Corp (INCY) · filed Jan 30, 2023
- Accession no.
- 0001209191-23-005451
- Filed
- Jan 30, 2023
- Trade date
- Jan 26, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $205.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dhanak DashyantCIK 0001760682 | Officer (EVP & Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2023 | Common Stock | SSaleDisposed | −2,419 | $85.00F1 | −$205,615 | 53,263 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Referenced by the price of 1 transaction in Table I.